Andrew Krakauer (Insider Trades), CEO of Cantel Medical Corp. (CMN), sold 22,981 shares of the company on Oct. 14. The per share was $54.22 for a total transaction of $1,246,030. Cantel Medical Corp. delivers infection prevention and control product and services for patients, caregivers, and other healthcare providers, which improve outcomes, enhance safety and help save lives. The company has a market cap of $2.23 billion and a P/S ratio of 4.02.
The number of insider sells ranged from 14 to 19 during 2012 to 2015. The volume of insider buys decreased by about 60% during the same period of time. There were 18 insider sells with the company in 2012, totaling 682,227 shares. In comparison, there were 19 insider sells of CMN totaling 210,821 shares in 2015. The month end price increased about three-fold during this time. 
Krakauer sold 384,925 shares of the company in 11 transactions since April 2010. The value increased about 800% since the sell. Director Ann Berman (Insider Trades) also sold 2,462 shares of the company on Oct. 5. The average price per share was $56.67. Additionally, CMN Chairman and 10% owner, Charles Diker (Insider Trades), also sold 27,415 shares three days before Berman. The average price per share was $56.24. For more information about insider transaction with the company, click here.
The company reported gross profit of $68.763 million for their fiscal fourth quarter ended on July 31. This is up from a gross profit of $57.047 million reported by CMN in the year-ago quarter. Net income also increased from $10.705 million, or 26 cents per share, to $13.273 million, or 32 cents per share. Annual net income for CMN increased 22.5% since 2010. 
Similarly, gross profit increased 18.67% since 2010. The company announced the acquisition of Medical Innovations Group Holdings on Sept. 14. Medical Innovations is a United Kingdom-based medical device company and is a leading provider of endoscope storage and transport systems in the UK and internationally. The purchase price of the company was $79.5 million in cash consideration. Jorgen Hansen, President and COO of Cantel Medical commented that the acquisition of Medical Innovations is a “significant opportunity for Cantel Medical to drive additional growth in the UK market.” Dividends per share increased 17.85% since 2010. 
According to GuruFocus.com information, CMN has a business predictability rank of 5 out of 5 stars. For more information about business predictability rank, click here.
Three gurus reduced their stake in the company during the second quarter of 2015. Joel Greenblatt (Trades, Portfolio) and Jim Simons (Trades, Portfolio) both sold all shares they held with CMN. Greenblatt sold 7,967 shares and Simons sold 9,300. Mario Gabelli (Trades, Portfolio) reduced his stake by 11.48%, selling 40,100 shares for an average price of $48.64. All three have consistently reduced their stake with CMN since the third quarter of 2014. For more information about guru trades with Cantel Medical, click here.
For more stock trades of gurus in real time, visit GuruFocus’ Real Time Picks, a Premium Feature. Not a Premium Member of GuruFocus? Try it free for 7 days here.
